CHST2 and chronic myelogenous leukemia, BCR-ABL1 positive: We selected a group of 26 genes, which had an absolute log2 fold-change of at least 0.7 in CMLD1 (only CHST2 and IDNK had smaller fold-changes) and had biological relevance for validation by qPCR in an independent cohort of five CML-CP patients and two healthy donors.